{"prompt": "['EudraCT Number 2019-002880-82, IRAS Number 1003208', 'K', \"ING'S\", 'College', \"Guy's and St Thomas'\", 'NHS', 'LONDON', 'NHS Foundation Trust', 'PROTOCOL FULL TITLE:', 'Randomised controlled trial of Gestational treatment with', 'Ursodeoxycholic Acid compared to Metformin to Reduce', 'effects of Diabetes mellitus', 'Protocol Short Title/Acronym:', 'GUARD', 'yst', 'Trial Identifiers', 'EudraCT Number - 2019-002880-82', 'IRAS Number - 1003208', 'REC Number - 20/LO/0504', 'ISRCTN -', 'NIHR portfolio number - 44480', 'EDGE ID - 128219', 'Sponsor', 'Co-sponsor', \"King's College London\", \"Guy's and St Thomas NHS Foundation\", 'Representative: Helen Critchley', 'Trust', \"King's Health Partners Clinical Trial\", 'Representative: Rachel Fay', \"Office, 16th Floor, Tower Wing, Guy's\", \"Guy's and St Thomas NHS Foundation\", 'Hospital, Great Maze Pond, London SE1', 'Trust R&D Department, 16th Floor Tower', '9RT', 'Wing, Great Maze Pond, London SE1', 'Telephone: 020 7188 5732', '9RT', 'Fax: 020 7188 8330', 'Telephone: 02071889811', 'helen.critchley@kcl.ac.uk', 'R&D@gstt.nhs.uk', 'GUARD protocol V1.0 11Mar20', 'Page 1 of 53']['EudraCT Number 2019-002880-82, IRAS Number 1003208', 'Chief Investigator', 'Professor Catherine Williamson', \"Professor of Women's Health\", \"Division of Women and Children's Health, King's College London, London SE1 1UL\", '020 7848 6350/020 7848 6014', 'catherine.williamson@kcl.ac.uk', 'Name and address of Co-Investigators', 'Prof Helen Murphy', 'Ms Claire Singh', 'Professor of Medicine', \"Research Matron - Women's\", \"Address: St Thomas' Hospital, London\", 'Services', 'lelen.1.murphy@kcl.ac.uk', \"Address: St Thomas' Hospital,\", 'London', 'Dr Caroline Ovadia', 'laire.Singh@gstt.nhs.uk', 'Chadburn Lecturer in Obstetrics and', 'Gynaecology', 'Dr Peter Dixon', \"Address: King's College London, London\", 'Research Fellow', 'caroline.ovadia@kcl.ac.uk', \"Address: King's College London,\", 'London', 'Dr Alice Mitchell', 'peter.dixon@kcl.ac.uk', 'Postdoctoral Research Associate', \"Address: King's College London, London\", 'Prof Kennedy Cruickshank', 'alice.mitchell@kcl.ac.uk', 'Professor of Cardiovascular', 'Medicine and Diabetes', 'Dr Annette Briley', \"Address: King's College London\", 'Consultant Midwife', \"and Guy's and St Thomas NHS FT,\", \"Address: St Thomas' Hospital, London\", 'London', 'annette.l.briley@kcl.ac.uk', 'Telephone: 02078484270', 'kennedy.cruickshank@kcl.ac.uk', 'Statistician', 'Mr Paul Seed', \"Address: King's College London, London\", 'Email: paul.seed@kcl.ac.uk', 'Clinical Trial Manager', 'Ms Sonia Serrano', \"NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust\", 'Telephone: 020 7188 7188 ext 53369; Sonia.serrano@gstt.nhs.uk', 'GUARD protocol V1.0 11Mar20', 'Page 2 of 53']['EudraCT Number 2019-002880-82, IRAS Number 1003208', '1. Study Synopsis', 'Randomised controlled trial of Gestational treatment', 'Title of clinical trial', 'with Ursodeoxycholic Acid compared to Metformin to', 'Reduce effects of Diabetes mellitus', 'Protocol Short Title/Acronym', 'GUARD', 'Trial Phase if not mentioned in', 'title', 'Pilot Phase 4 RCT', 'Sponsor name', \"King's College London & Guy's and St Thomas' NHS\", 'Foundation Trust', 'Chief Investigator', 'Professor Catherine Williamson', 'EudraCT number', '2019-002880-82', 'REC number', '31/03/2020', 'Medical condition or disease', 'Gestational Diabetes Mellitus (GDM)', 'under investigation', 'To compare the impact of treatment with', 'Purpose of clinical trial', 'ursodeoxycholic acid vs metformin on glycaemic', 'control in women with GDM', 'To assess the efficacy of UDCA compared', 'to', 'Primary objective', 'metformin to improve glycaemic control in GDM.', '-', 'To evaluate the impact of the treatments on', 'maternal and neonatal lipid metabolism.', '- To assess the acceptability of UDCA compared to', 'metformin to women with GDM.', '-', 'To establish whether continuous glucose', 'Secondary objective (s)', 'monitoring gives more informative overall', 'assessment of maternal glycaemic control in', 'overweight or obese pregnant women.', '- To evaluate vascular responses in each arm.', '- To compare maternal and fetal outcomes that', 'could relate to treatment with UDCA or metformin.', 'Two-armed, randomised, controlled, open label', 'Trial Design', 'multicentre clinical trial with optional observational', 'mechanistic study in a subgroup from each arm', 'P - Pregnant women of a BMI >25 with GDM', 'requiring pharmacological treatment', 'PICO', 'I - UDCA 500mg BD', 'C - Metformin 1000mg BD', 'O - Fasting glucose concentration at 36 weeks', 'gestation', 'Endpoints', '- Maternal fasting glucose concentration at 36', 'weeks gestation measured with a blood sample.', 'GUARD protocol V1.0 11Mar20', 'Page 3 of 53']\n\n###\n\n", "completion": "END"}